Addex Therapeutics (ADXN) Current Deferred Revenue (2018 - 2020)
Addex Therapeutics (ADXN) posted Current Deferred Revenue of $811551.0 for Q4 2020, down 15.07% sequentially from $955557.2 in Q4 2019, and down 15.07% YoY from $955557.2 in Q1 2020.
Addex Therapeutics (ADXN) Current Deferred Revenue (2018 - 2020) Analysis & Trends
Addex Therapeutics has reported Current Deferred Revenue for 3 years, with the latest figure at $811551.0 in Q4 2020.
- Quarterly Current Deferred Revenue fell 15.07% year-over-year to $811551.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $811551.0 (down 15.07% YoY) and the FY2020 annual result came in at $811551.0, down 14.76% from the prior year.
- Current Deferred Revenue slipped to $811551.0 in Q4 2020 per ADXN's latest filing, from $955557.2 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $955557.2 in Q4 2019 and troughed at $213772.6 in Q4 2018.
- A 3-year average of $660293.6 and a median of $811551.0 in 2020 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2019 and 2020: Current Deferred Revenue jumped 347.0% in 2019, then declined 15.07% in 2020.
- Over 3 years, Current Deferred Revenue stood at $213772.6 in 2018, then soared by 347.0% to $955557.2 in 2019, then slipped by 15.07% to $811551.0 in 2020.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $811551.0, $955557.2, and $213772.6 for Q4 2020, Q4 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 811,550.98 |
| Dec 31, 2019 | 955,557.18 |
| Dec 31, 2018 | 213,772.57 |